Moreover, after vaccination, IL-6 expression was lower in patients with good response compared to patients with poor response, which was in line with a published study concluding that the elevation of IL-6 correlated with poor survival in pancreatic cancer patients (40). This evidence concerns the gene IL6 and familial pancreatic carcinoma.